Departamento
CIENCIAS BIOMÉDICAS
Publicaciones (10) Publicaciones en las que ha participado algún/a investigador/a
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (Nature Genetics, (2023), 55, 1, (89-99), 10.1038/s41588-022-01222-9)
Nature Genetics
-
Correction to: Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells (Cancers, (2019), 11, 12, (1984), 10.3390/cancers11121984)
Cancers
-
Corrigendum to “An optimized centrifugation protocol for ram sperm ensuring high sample yield, quality and fertility” [Theriogenology 191 (2022) 179–191, (S0093691X2200293X), (10.1016/j.theriogenology.2022.08.006)]
Theriogenology
-
Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer” (eBioMedicine (2023) 92, (S2352396423001810), (10.1016/j.ebiom.2023.104616))
eBioMedicine
-
Corrigendum: Role of NAFLD on the health related QoL response to lifestyle in patients with metabolic syndrome: The PREDIMED plus cohort(Front. Endocrinol., (2022), 13, (868795), 10.3389/fendo.2022.868795)
Frontiers in Endocrinology
-
Creation of a Pediatric Hospital Medicine Subspecialty in Spain
Hospital Pediatrics
-
Erratum: A comparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells (British Journal of Nutrition (2008) 100: 5 (968-976) DOI: 10.1017/S0007114508966083)
British Journal of Nutrition
-
Population health surveys and screening tools for depressive disorders: Aims and uses
BMJ Mental Health
-
Therapeutic approaches in intermediate-stage hepatocellular carcinoma (HCC): a novel insight of adjuvant transarterial chemoembolization (TACE)
Chinese Clinical Oncology